Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling …
How A Wall Street Analyst Started A $4 Billion Obesity Drug Company
view original post